As one of the world's largest drugmakers, AbbVie Inc. (NYSE: ABBV)is made of many moving pieces. The big one at the top, Humira, can't keep growing forever. In fact, its main U.S. patent has already expired.
3 Reasons to Expect Smooth Sailing for AbbVie's Mission-Critical Candidate
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться